Funding Of Two Science Labs Revives Pork Barrel Vs. Peer Review Debate

Controversy over propriety is rekindled as new physics and marine biotech centers make their respective moves to gain federal allocations WASHINGTON--Buried within the 1992 appropriations bill signed last month by President Bush for NASA, the National Science Foundation, and several other federal agencies is an allocation of $43 million to start the building of two new academic research facilities. One--a $211 million observatory to measure gravity waves, to be built at two sites thousands of

Written byJeffrey Mervis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

One--a $211 million observatory to measure gravity waves, to be built at two sites thousands of miles apart--has undergone extensive peer review by scientists and a federal research agency and has been a part of the president's budget for the past two years. The other--a $130 million marine biotechnology center in downtown Baltimore--is a project pushed successfully for the past three years by its home state's congressional delegation.

Maryland's legislators are hardly the first to bypass scientific peer review in a drive for federal funds. Although several reports have documented a multibillion-dollar need to repair and upgrade the country's aging research laboratories, the question of how best to obtain such funds remains unresolved.

Although their projects entered the political process via different routes, the lobbyists hired to promote LIGO and the Columbus marine center say they agree on the right way to fund academic research facilities. In fact, it's hard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies